Showing results (1201-1210 of 1,217) with videos related to

Sort By:
Pageof 122
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
Cladistics : the International Journal of the Willi Hennig Society|November 2, 2021
The spider tree of life: phylogeny of Araneae based on target-gene analyses from an extensive taxon samplingWard C Wheeler, Jonathan A Coddington, Louise M Crowley, et al.
Environmental Evidence|September 18, 2024
Herbivore diversity effects on Arctic tundra ecosystems: a systematic reviewLaura Barbero-Palacios, Isabel C Barrio, Mariana García Criado, et al.
Biological Psychiatry|February 24, 2020
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's DiseaseNatalie Ellis, Amelia Tee, Branduff McAllister, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects, Jong-Min Lee, Zachariah L McLean, et al.
American Journal of Medical Genetics. Part A|July 2, 2013
The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypesCynthia J Curry, Jill A Rosenfeld, Erica Grant, et al.
Plos One|June 16, 2012
Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous systemJohn F Staropoli, Larissa Haliw, Sunita Biswas, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Pageof 122